Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Hillary Graham
Observed names:
Hillary T Graham,
Hillary T. Graham
Observed institutions:
North Carolina State University,
Eli Lilly (United States)
ORCID:
0000-0001-5850-1551
Observed ORCID:
0000-0001-5850-1551
OpenAlex ID:
A5055152134
Landscape of Baseline and Acquired Genomic Alterations in Circulating Tumor DNA with Abemaciclib Alone or with Endocrine Therapy in Advanced Breast Cancer
2023
·
Matthew P. Goetz
, Erika P. Hamilton
, et al.
·
Clinical Cancer Research
·
46
PDF
RELAY, Ramucirumab Plus Erlotinib (RAM+ERL) in Untreated Metastatic EGFR-Mutant NSCLC (EGFR+ NSCLC): Association Between TP53 Status and Clinical Outcome
2023
·
Makoto Nishio
, Luis Paz-Ares
, et al.
·
Clinical Lung Cancer
·
27
Acquired genomic alterations in circulating tumor DNA from patients receiving abemaciclib alone or in combination with endocrine therapy.
2020
·
Matthew P. Goetz
, Erika Paige Hamilton
, et al.
·
Journal of Clinical Oncology
·
26
Abstract 785: Genomic markers of response to monotherapy abemaciclib in the nextMONARCH 1 study
2020
·
Erika P. Hamilton
, Javier Cortes
, et al.
·
Cancer Research
·
6
Abstract PD2-06: Efficacy of abemaciclib based on genomic alterations detected in baseline circulating tumor DNA from the MONARCH 3 study of abemaciclib plus nonsteroidal aromatase inhibitor
2020
·
Matthew P Goetz
, J. Thaddeus Beck
, et al.
·
Cancer Research
·
5
Incorporating Concomitant Medications into Genome-Wide Analyses for the Study of Complex Disease and Drug Response
2016
·
Hillary T. Graham
, Daniel M. Rotroff
, et al.
·
Frontiers in Genetics
·
3
PDF
Data from Landscape of Baseline and Acquired Genomic Alterations in Circulating Tumor DNA with Abemaciclib Alone or with Endocrine Therapy in Advanced Breast Cancer
2024
·
Matthew P. Goetz
, Erika P. Hamilton
, et al.
·
2
Data from Landscape of Baseline and Acquired Genomic Alterations in Circulating Tumor DNA with Abemaciclib Alone or with Endocrine Therapy in Advanced Breast Cancer
2024
·
Matthew P. Goetz
, Erika P. Hamilton
, et al.
·
1
Supplementary Data 1 from Landscape of Baseline and Acquired Genomic Alterations in Circulating Tumor DNA with Abemaciclib Alone or with Endocrine Therapy in Advanced Breast Cancer
2024
·
Matthew P. Goetz
, Erika P. Hamilton
, et al.
Supplementary Data 1 from Landscape of Baseline and Acquired Genomic Alterations in Circulating Tumor DNA with Abemaciclib Alone or with Endocrine Therapy in Advanced Breast Cancer
2024
·
Matthew P. Goetz
, Erika P. Hamilton
, et al.
Genomic markers of response to monotherapy abemaciclib in the nextMONARCH 1 study
2020
·
Erika Hamilton
, Javier Cortés
, et al.
Incorporating Concomitant Medications into Linear Models for Genome-Wide Association Studies.
2015
·
Hillary Graham
·
NCSU Libraries Repository (North Carolina State University Libraries)
PDF
Show more works
View as search
Works count:
12
Citation count:
116
H-index:
5
I10-index:
3
Year
Topic
Type
